Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →

All 165Congress 0Executive branch 0Insiders 165
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

TRDA · $50K+ · 165 trades

Trades
165
Buys 0 · Sells 165
People
20
Stocks
1
Disclosed value
$55.7M
range midpoints · Congress & executive
Filed late
13
  1. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  2. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  3. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  4. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  5. ▼ SELLMPM BioVentures 2014, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  6. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  7. ▼ SELLMPM BioVentures 2014 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  8. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  9. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  10. ▼ SELLTodd Foley 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  11. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  12. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  13. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  14. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  15. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  16. ▼ SELLMpm Bioventures 2018 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  17. ▼ SELLMpm Bioventures 2018, L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  18. ▼ SELLMPM BioVentures 2014 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  19. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade
  20. ▼ SELLMPM BioVentures 2014 (B), L.P. 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  21. ▼ SELLMPM BioVentures 2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  22. ▼ SELLLuke Evnin 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  23. ▼ SELLMpm Asset Management Investors Bv2018 LLC 10% ownerTRDA Entrada Therapeutics, Inc.$231Kdisclosed Sep 3 · filed the same day
  24. ▼ SELLMPM BioVentures 2018 GP LLC 10% ownerTRDA Entrada Therapeutics, Inc.$181Kdisclosed Sep 3 · filed 1 day after the trade
  25. ▼ SELLAnsbert Gadicke 10% ownerTRDA Entrada Therapeutics, Inc.$205Kdisclosed Sep 3 · filed 2 days after the trade